Hao Li
Finanzdirektor/CFO bei SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Profil
Hao Li currently works at China National Pharmaceutical Industry Corp.
Ltd., as Director, Qinghai Pharmaceutical (Group) Co., Ltd., as Director, Sinopharm Holding Heze Co., Ltd., as Director, and Shanghai Shyndec Pharmaceutical Co., Ltd., as Chief Financial Officer & Vice President from 2023.
Mr. Li also formerly worked at Shanghai Shyndec Pharmaceutical Co., Ltd., as Chief Financial Officer from 2016 to 2019.
Aktive Positionen von Hao Li
Unternehmen | Position | Beginn |
---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Finanzdirektor/CFO | 28.06.2023 |
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - |
Qinghai Pharmaceutical (Group) Co., Ltd.
Qinghai Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: OtherHealth Technology Qinghai Pharmaceutical (Group) Co., Ltd. engages in the export of medicines and chemical products. It offers rivanol, hydrochloric acid apomorphine, papaverine hydrochloride, and chemical raw materials. The company was founded on January 17, 2000 and is headquartered in Xining, China. | Direktor/Vorstandsmitglied | - |
Sinopharm Holding Heze Co., Ltd.
Sinopharm Holding Heze Co., Ltd. Financial ConglomeratesFinance Sinopharm Holding Heze Co., Ltd. engages in the sale of Chinese medicines, chemical preparations, and biological products. It also offers medical equipment, dairy products, cosmetics and hygiene products, and biochemical products. Its business activities include domestic advertising, economic and trade consulting, enterprise management, corporate marketing, conference and exhibition services, office equipment leasing, warehousing services, and freight forwarding services. The company was founded on March 7, 2007 and is headquartered in Heze, China. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hao Li
Unternehmen | Position | Ende |
---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Finanzdirektor/CFO | 28.05.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Health Technology |
Qinghai Pharmaceutical (Group) Co., Ltd.
Qinghai Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: OtherHealth Technology Qinghai Pharmaceutical (Group) Co., Ltd. engages in the export of medicines and chemical products. It offers rivanol, hydrochloric acid apomorphine, papaverine hydrochloride, and chemical raw materials. The company was founded on January 17, 2000 and is headquartered in Xining, China. | Health Technology |
Sinopharm Holding Heze Co., Ltd.
Sinopharm Holding Heze Co., Ltd. Financial ConglomeratesFinance Sinopharm Holding Heze Co., Ltd. engages in the sale of Chinese medicines, chemical preparations, and biological products. It also offers medical equipment, dairy products, cosmetics and hygiene products, and biochemical products. Its business activities include domestic advertising, economic and trade consulting, enterprise management, corporate marketing, conference and exhibition services, office equipment leasing, warehousing services, and freight forwarding services. The company was founded on March 7, 2007 and is headquartered in Heze, China. | Finance |